Ekso Bionics holder entity buys 1,200 EKSO shares

Ekso Bionics Holdings insider activity centers on an indirect open-market purchase and updated holdings.

Rhea-AI Filing Summary

Ekso Bionics Holdings insider activity centers on an indirect open-market purchase and updated holdings. An entity associated with major shareholder Daniel Asher, DBA Trading, LLC, bought 1,200 shares of common stock at $9.60 per share, increasing its indirect position to 259,992 common shares. Asher is described as the beneficial owner of DBA Trading, LLC with voting and dispositive control over these shares.

The filing also reports indirect holdings of 355,961 shares of convertible preferred stock through the Daniel Asher Descendants Trust, where Asher is grantor and controls voting and dispositive power, and 165,000 common shares held directly. The preferred and direct common entries are reported as holdings rather than new transactions.

Insider Trade Summary

Net Buyer: 1,200 shares

Net Buy 3 txns

Insider ASHER DANIEL

Role 10% Owner

Bought 1,200 shs ($12K)

Type	Security	Shares	Price	Value
Purchase	Common Stock	1,200	$9.60	$12K
holding	Convertible Preferred Stock	--	--	--
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 259,992 shares (Indirect, by DBA Trading, LLC); Convertible Preferred Stock — 355,961 contracts (Indirect, By Daniel Asher Descendants Trust); Common Stock — 165,000 shares (Direct)

Footnotes (3)

1. F1. Daniel Asher is the beneficial owner of DBA Trading, LLC and deemed to control share voting and dispositive power over the shares held by them.
2. F2. Daniel Asher is grantor of Daniel Asher Descendants Trust and deemed to control share voting and dispositive power over the shares held by them.
3. F3. None

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did EKSO reporting person Daniel Asher disclose?

The filing reports an indirect open-market purchase of 1,200 Ekso Bionics common shares at $9.60 per share. The trade was made by DBA Trading, LLC, an entity Asher beneficially owns and controls for voting and dispositive decisions over the held shares.

Who actually purchased Ekso Bionics (EKSO) shares in this Form 4 filing?

The purchase was made by DBA Trading, LLC, an entity associated with Daniel Asher. Asher is identified as the beneficial owner of DBA Trading, LLC and is deemed to control voting and dispositive power over the 259,992 Ekso Bionics common shares held by that entity.

How many Ekso Bionics (EKSO) shares does the DBA Trading, LLC entity hold after the transaction?

After buying 1,200 common shares at $9.60 per share, DBA Trading, LLC is reported as holding 259,992 Ekso Bionics common shares. Daniel Asher is deemed the beneficial owner of this entity, with control over how these shares are voted and potentially sold.

What preferred stock holdings related to Ekso Bionics (EKSO) does Daniel Asher report?

The filing lists 355,961 shares of Ekso Bionics convertible preferred stock held indirectly through the Daniel Asher Descendants Trust. Asher is described as the grantor of this trust and is deemed to control voting and dispositive power over the preferred shares reported in the Form 4.

Does Daniel Asher report any direct ownership of Ekso Bionics (EKSO) common stock?

Yes. In addition to indirect holdings, the Form 4 shows Daniel Asher directly holding 165,000 Ekso Bionics common shares. This line is categorized as a holding entry, reflecting the number of common shares directly owned after the reported date rather than a new market transaction.

Is this Ekso Bionics (EKSO) Form 4 primarily a buy or sell disclosure?

The Form 4 primarily reflects a net-buy disclosure. It shows one indirect open-market purchase of 1,200 Ekso Bionics common shares through DBA Trading, LLC and no reported sales, alongside updates to indirect and direct holdings of preferred and common stock positions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/19/2026 - 04:03 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ASHER DANIEL

(Last) (First) (Middle)

1011 LAKE ST

SUITE 311

(Street)

OAK PARK IL 60301

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EKSO BIONICS HOLDINGS, INC. [ EKSO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
02/17/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	02/19/2026		P		1,200	A	$9.6	259,992	I	by DBA Trading, LLC(1)
Common Stock								165,000	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Convertible Preferred Stock	$8.22							01/22/2026	(3)	Common Stock	355,961		2,926	I	By Daniel Asher Descendants Trust(2)

Explanation of Responses:

1. Daniel Asher is the beneficial owner of DBA Trading, LLC and deemed to control share voting and dispositive power over the shares held by them.

2. Daniel Asher is grantor of Daniel Asher Descendants Trust and deemed to control share voting and dispositive power over the shares held by them.

3. None

	Daniel Asher	02/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.